PyInvesting

Market research

LBIRD.PA Lumibird SA

PA EUR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
560M
P/E ratio
39.69
Analyst target
32.1667
Dividend yield
0.0%
Beta
0.93

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Lumibird SA is currently in a long term uptrend where the price is trading 8.2% above its 200 day moving average.

From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.

Finally, its free cash flow fell by 68.1% to $3M since the same quarter in the previous year.

Based on the above factors, Lumibird SA gets an overall score of 2/5.